Gautam U Mehta1,2, Blake K Montgomery1, Dominic M Maggio1,2, Prashant Chittiboina1, Edward H Oldfield1,2, Russell R Lonser1,3. 1. Surgical Neurology Branch, National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland. 2. Department of Neurosurgery, University of Virginia Health Sciences Center, University of Virginia, Charlottesville, Virginia. 3. Department of Neurosurgery, Ohio State University Wexner Medical Center, Columbus, Ohio.
Abstract
BACKGROUND: Cauda equina hemangioblastomas in von Hippel-Lindau (VHL) disease can cause significant neurological signs and symptoms. Despite their associated morbidity, the management of these tumors remains incompletely defined. OBJECTIVE: To determine optimal management, we analyzed the functional outcomes after resection of these tumors. METHODS: VHL patients who underwent surgical resection of cauda equina hemangioblastomas at the National Institutes of Health and the University of Virginia were included. Clinical and radiological follow-up was performed at 6- to 12-month intervals after surgery. RESULTS: Fifteen patients underwent 18 operations for 21 cauda equina hemangioblastomas (median follow-up 5.9 years). Patients often presented with multiple symptoms, including pain (67%), numbness (50%), urinary complaints (33%), and weakness (11%). Median preoperative tumor volume was 1.2 cm 3 . Four tumors at 3 operations were not resected due to a motor nerve root origin. Gross total resection was achieved in 14 surgeries (93% of operations when resection was attempted). New mild (non-function limiting) neurological symptoms were noted after 11 operations (61%), which most often (64%) resolved within 2 weeks of surgery. At 6-month follow-up, 15 patients (83%) were stable, 2 (11%) were improved, and 1 (6%) was worse. Histological analysis revealed that all tumors originated from within the involved nerve fascicle. CONCLUSIONS: VHL-associated cauda equina hemangioblastomas have an intrafascicular origin and require interruption of the rootlet of origin for complete resection. Motor nerve root involvement may preclude complete resection but strategies including bony decompression and/or interruption of vascular supply may provide a therapeutic option. Nevertheless, most VHL patients with symptom-producing lesions improve with resection. Published by Oxford University Press on behalf of the Congress of Neurological Surgeons 2017.
BACKGROUND:Cauda equina hemangioblastomas in von Hippel-Lindau (VHL) disease can cause significant neurological signs and symptoms. Despite their associated morbidity, the management of these tumors remains incompletely defined. OBJECTIVE: To determine optimal management, we analyzed the functional outcomes after resection of these tumors. METHODS:VHLpatients who underwent surgical resection of cauda equina hemangioblastomas at the National Institutes of Health and the University of Virginia were included. Clinical and radiological follow-up was performed at 6- to 12-month intervals after surgery. RESULTS: Fifteen patients underwent 18 operations for 21 cauda equina hemangioblastomas (median follow-up 5.9 years). Patients often presented with multiple symptoms, including pain (67%), numbness (50%), urinary complaints (33%), and weakness (11%). Median preoperative tumor volume was 1.2 cm 3 . Four tumors at 3 operations were not resected due to a motor nerve root origin. Gross total resection was achieved in 14 surgeries (93% of operations when resection was attempted). New mild (non-function limiting) neurological symptoms were noted after 11 operations (61%), which most often (64%) resolved within 2 weeks of surgery. At 6-month follow-up, 15 patients (83%) were stable, 2 (11%) were improved, and 1 (6%) was worse. Histological analysis revealed that all tumors originated from within the involved nerve fascicle. CONCLUSIONS:VHL-associated cauda equina hemangioblastomas have an intrafascicular origin and require interruption of the rootlet of origin for complete resection. Motor nerve root involvement may preclude complete resection but strategies including bony decompression and/or interruption of vascular supply may provide a therapeutic option. Nevertheless, most VHLpatients with symptom-producing lesions improve with resection. Published by Oxford University Press on behalf of the Congress of Neurological Surgeons 2017.
Entities:
Keywords:
Cauda equina; Hemangioblastoma; Lumbosacral; Nerve root; von Hippel-Lindau disease
Authors: Alessandra Biondi; Giuseppe K Ricciardi; Tierry Faillot; Laurent Capelle; Rémy Van Effenterre; Jacques Chiras Journal: AJNR Am J Neuroradiol Date: 2005-04 Impact factor: 3.825
Authors: Kristin Huntoon; Tianxia Wu; J Bradley Elder; John A Butman; Emily Y Chew; W Marston Linehan; Edward H Oldfield; Russell R Lonser Journal: J Neurosurg Date: 2015-10-30 Impact factor: 5.115
Authors: Sven Gläsker; Ansgar Berlis; Axel Pagenstecher; Vassilios I Vougioukas; Vera Van Velthoven Journal: Neurosurgery Date: 2005-03 Impact factor: 4.654
Authors: Russell R Lonser; John A Butman; Kristin Huntoon; Ashok R Asthagiri; Tianxia Wu; Kamran D Bakhtian; Emily Y Chew; Zhengping Zhuang; W Marston Linehan; Edward H Oldfield Journal: J Neurosurg Date: 2014-02-28 Impact factor: 5.115
Authors: Lisa B E Shields; John E Harpring; Hilary A Highfield; Yi Ping Zhang; Christopher B Shields Journal: J Neurosurg Case Lessons Date: 2021-04-26
Authors: Salvatore D' Oria; David Giraldi; Daniel Andres Alvarado Flores; Domenico Murrone; Vincenzo D' Angelo; Bipin Chaurasia Journal: J Craniovertebr Junction Spine Date: 2022-09-14
Authors: Henrique Oliveira Martins; Roger Schmidt Brock; Mario Augusto Taricco; José Francisco Pereira Júnior; Matheus Fernandes de Oliveira Journal: Surg Neurol Int Date: 2019-04-24